• News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • News
  • Stock Screener
  • Small Caps
  • Guru Portfolios
  • Review
  • X (Twitter)
  • LinkedIn
Stock Screener·India·Basic Materials·ARISTO-SM.NS
Share

ARISTO BIO T AND LIFESC L Stocks

₹ 89.3Last Updated 16.10.2026

Issuer Rating

3/7
Performance

Favourable

Risk

High

Recommendation

Sell

Market Cap

₹ 12.92M

₹ 89.3
Key Takeaways

Risk factor

Very high price volatility

Data is available to registered users only
Data is available to registered users only

Profitability factor

Strong growth

Data is available to registered users only
Data is available to registered users only
Sign up to get free access to key risk and return factors, detailed company valuation, and analyst forecasts
Sign up to access all the key risk and return factors

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

About

Aristo Bio-tech An is an Indian enterprise specializing in the agricultural chemicals industry. Its primary business involves the contract manufacturing, formulation, and packaging of a variety of crop protection products. These offerings include pest control agents, weed eradication compounds, anti-fungal treatments, and plant development regulators, which the company distributes to both its domestic market in India and international clients.

Company Valuation

Slightly undervalued
5/7

Based on key historical and expected multiples, the stock is slightly undervalued relative to its peers. Specifically, the stock is 'cheap' on P/E, undervalued on EV/EBIT

Data is available to registered users only
Sign up to access detailed valuation

Risks

  • Default risk
    Data is available to registered users only
  • Volatility
    Data is available to registered users only
  • Selling difficulty
    Data is available to registered users only
  • Stress test
    Data is available to registered users only
  • Country risks
    Data is available to registered users only
  • Other risks
    Data is available to registered users only
Sign up to access detailed risk analysis

Trending

21.10.2026 14:09

Stocks in the memory sector fell by up to 25% last week. Is it worth buying on the dip?

21.10.2026 12:57

Shares of the French retail giant plummeted after the company lowered its forecast amid protests

21.10.2026 12:23

Buying on a Pullback: Why Tom Lee Isn't Worried About the Jitters Surrounding AI Stock Companies

21.10.2026 11:24

The AI market is "almost certainly" in a bubble — billionaire Ken Griffin

21.10.2026 10:45

Netflix issued a weak forecast and scaled back its advertising plans. What is Wall Street saying?

X-channel

Buy

Sell

0 more stocks

Company

  • About
  • Contributors
  • Contacts
  • Legal Information

Social media

  • X (Twitter)
  • LinkedIn

Services

  • Stock Screener
  • Guru Portfolios
  • X (Twitter)
  • LinkedIn
Oninvest© 2026